Lengthy Testimonies in Philadelphia Court Could Transform Lawsuit Against Ozempic and Other GLP-1 Drugmakers

May 19, 2025

Follow:

Disclosure: This website may contain affiliate links, which means I may earn a commission if you click on the link and make a purchase. I only recommend products or services that I personally use and believe will add value to my readers. Your support is appreciated!

Hours of testimony in Philadelphia federal court on Ozempic and other GLP-1 drugs could significantly impact ongoing lawsuits against manufacturers, as detailed in the Pittsburgh Post-Gazette.

—-

Author : Charlotte Adams

Publish date : 2025-05-19 00:30:00

Copyright for syndicated content belongs to the linked Source.

—-

1 – 2 – 3 – 4 – 5 – 6 – 7 – 8